These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 15897561

  • 21. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R, Li BZ, Ling YQ, Zhang HP, Li H, Liu Y, Hu XQ, Zhu HG.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
    [Abstract] [Full Text] [Related]

  • 22. Molecular profiling and classification of sporadic renal cell carcinoma by quantitative methylation analysis.
    Gonzalgo ML, Yegnasubramanian S, Yan G, Rogers CG, Nicol TL, Nelson WG, Pavlovich CP.
    Clin Cancer Res; 2004 Nov 01; 10(21):7276-83. PubMed ID: 15534102
    [Abstract] [Full Text] [Related]

  • 23. Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis.
    van Dekken H, Verhoef C, Wink J, van Marion R, Vissers KJ, Hop WC, de Man RA, IJzermans JN, van Eijck CH, Zondervan PE.
    Acta Histochem; 2005 Nov 01; 107(3):161-71. PubMed ID: 16000213
    [Abstract] [Full Text] [Related]

  • 24. NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma.
    Macheiner D, Heller G, Kappel S, Bichler C, Stättner S, Ziegler B, Kandioler D, Wrba F, Schulte-Hermann R, Zöchbauer-Müller S, Grasl-Kraupp B.
    J Hepatol; 2006 Jul 01; 45(1):81-9. PubMed ID: 16516329
    [Abstract] [Full Text] [Related]

  • 25. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C, Li Z, Cheng Y, Jia F, Li R, Wu M, Li K, Wei L.
    Clin Cancer Res; 2007 Feb 01; 13(3):944-52. PubMed ID: 17289889
    [Abstract] [Full Text] [Related]

  • 26. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO, Topaloglu O, Begum S, Henrique R, Rosenbaum E, Van Criekinge W, Westra WH, Sidransky D.
    J Clin Oncol; 2005 Sep 20; 23(27):6569-75. PubMed ID: 16170165
    [Abstract] [Full Text] [Related]

  • 27. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK.
    Clin Cancer Res; 2008 May 01; 14(9):2664-72. PubMed ID: 18451230
    [Abstract] [Full Text] [Related]

  • 28. Differential diagnosis of hepatocellular nodular lesions.
    Hytiroglou P, Theise ND.
    Semin Diagn Pathol; 1998 Nov 01; 15(4):285-99. PubMed ID: 9845429
    [Abstract] [Full Text] [Related]

  • 29. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients.
    Wang J, Qin Y, Li B, Sun Z, Yang B.
    Clin Biochem; 2006 Apr 01; 39(4):344-8. PubMed ID: 16527261
    [Abstract] [Full Text] [Related]

  • 30. [Correlation between hypomethylation of c-myc and c-N-ras oncogenes and pathological changes in human hepatocellular carcinoma].
    Shen L, Qui D, Fang J.
    Zhonghua Zhong Liu Za Zhi; 1997 May 01; 19(3):173-6. PubMed ID: 10920889
    [Abstract] [Full Text] [Related]

  • 31. Correlation between DNA methylation and pathological changes in human hepatocellular carcinoma.
    Shen L, Fang J, Qiu D, Zhang T, Yang J, Chen S, Xiao S.
    Hepatogastroenterology; 1998 May 01; 45(23):1753-9. PubMed ID: 9840141
    [Abstract] [Full Text] [Related]

  • 32. Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization.
    Steinemann D, Skawran B, Becker T, Tauscher M, Weigmann A, Wingen L, Tauscher S, Hinrichsen T, Hertz S, Flemming P, Flik J, Wiese B, Kreipe H, Lichter P, Schlegelberger B, Wilkens L.
    Clin Gastroenterol Hepatol; 2006 Oct 01; 4(10):1283-91. PubMed ID: 16979954
    [Abstract] [Full Text] [Related]

  • 33. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G.
    Gastroenterology; 2008 Dec 01; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [Abstract] [Full Text] [Related]

  • 34. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan.
    Hsu LS, Lee HC, Chau GY, Yin PH, Chi CW, Lui WY.
    Oncol Rep; 2006 Feb 01; 15(2):507-11. PubMed ID: 16391877
    [Abstract] [Full Text] [Related]

  • 35. Aberrant methylation of secreted apoptosis-related protein 2 (SARP2) in pure pancreatic juice in diagnosis of pancreatic neoplasms.
    Watanabe H, Okada G, Ohtsubo K, Yao F, Jiang PH, Mouri H, Wakabayashi T, Sawabu N.
    Pancreas; 2006 May 01; 32(4):382-9. PubMed ID: 16670620
    [Abstract] [Full Text] [Related]

  • 36. Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver.
    Haas S, Merkelbach-Bruse S, Justenhoven C, Brauch H, Fischer HP.
    Pathol Res Pract; 2009 May 01; 205(10):716-25. PubMed ID: 19596526
    [Abstract] [Full Text] [Related]

  • 37. Quantitative methylation analysis of multiple genes using methylation-sensitive restriction enzyme-based quantitative PCR for the detection of hepatocellular carcinoma.
    Hua D, Hu Y, Wu YY, Cheng ZH, Yu J, Du X, Huang ZH.
    Exp Mol Pathol; 2011 Aug 01; 91(1):455-60. PubMed ID: 21600201
    [Abstract] [Full Text] [Related]

  • 38. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
    Ko E, Kim Y, Kim SJ, Joh JW, Song S, Park CK, Park J, Kim DH.
    Cancer Epidemiol Biomarkers Prev; 2008 Sep 01; 17(9):2260-7. PubMed ID: 18723830
    [Abstract] [Full Text] [Related]

  • 39. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M, Utsunomiya T, Wakiyama S, Hashimoto M, Fukuzawa K, Ezaki T, Hanai T, Inoue H, Mori M.
    Ann Surg Oncol; 2006 Jul 01; 13(7):947-54. PubMed ID: 16788756
    [Abstract] [Full Text] [Related]

  • 40. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.
    Lv Z, Zhang M, Bi J, Xu F, Hu S, Wen J.
    Am J Clin Pathol; 2006 May 01; 125(5):740-6. PubMed ID: 16707376
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.